{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T10:55:13Z","timestamp":1756810513035,"version":"3.40.5"},"reference-count":30,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n<jats:title>Background and Aims:<\/jats:title>\n<jats:p>To study the prevalence of deranged metabolic parameters in patients\nwith gout.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>This was a prospective, cross-sectional observational study conducted at a tertiary level\nrheumatology center in Nepal. Patients over 18 years and diagnosed as gout using the ACR\/EULAR\n2015 classification criteria were included in the study. Known cases of chronic kidney disease,\nliver disease and heart diseases were excluded. Baseline demographic data along with records\nof weight, waist circumference, lipid profile, glucose profile, blood pressure measurement, serum\nuric acid level and inflammatory markers were taken. Diagnosis of metabolic syndrome (MS) was\nmade according to the National Cholesterol Education Program criteria. Approval was obtained\nfrom the ethical review board of the National Center for Rheumatic Diseases.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>A total of 523 patients with gout were enrolled in the study, out of which 97.0% were\nmale. The mean age at diagnosis was 49.1\u00b112.8 years. Most of the patients were overweight with a\nmean BMI of 27.0\u00b13.6 kg\/m2. About 8.1% had preexisting diabetes mellitus, 24.6% had hypertension,\n5.1% had hypothyroidism and 45.1% had dyslipidemia. Patients fulfilling 2 out of 5 criteria\nof MS were 60.6% whereas 30.6% fulfilled 3 out of 5 criteria.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Gout was commonly observed in middle-aged men. The prevalence of metabolic syndrome\nand its components was high in patients with gout. Management of gout should also include\nscreening and management of the metabolic syndrome.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871530320999200818141032","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T10:33:06Z","timestamp":1598005986000},"page":"1090-1095","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Study of Metabolic Parameters in Patients with Gout: A Single Center Study from Nepal"],"prefix":"10.2174","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4840-8924","authenticated-orcid":true,"given":"Binit","family":"Vaidya","sequence":"first","affiliation":[{"name":"National Center for Rheumatic Diseases, Kathmandu,Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3337-7360","authenticated-orcid":true,"given":"Rikesh","family":"Baral","sequence":"additional","affiliation":[{"name":"National Center for Rheumatic Diseases, Kathmandu,Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1979-8863","authenticated-orcid":true,"given":"Lakpa Dolma","family":"Lama","sequence":"additional","affiliation":[{"name":"National Center for Rheumatic Diseases, Kathmandu,Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4310-7169","authenticated-orcid":true,"given":"Rakshya","family":"Joshi","sequence":"additional","affiliation":[{"name":"National Center for Rheumatic Diseases, Kathmandu,Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5075-7683","authenticated-orcid":true,"given":"Manisha","family":"Bhochhibhoya","sequence":"additional","affiliation":[{"name":"National Center for Rheumatic Diseases, Kathmandu,Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6217-1516","authenticated-orcid":true,"given":"Shweta","family":"Nakarmi","sequence":"additional","affiliation":[{"name":"National Center for Rheumatic Diseases, Kathmandu,Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jare.2017.04.008","volume":"8","author":"Ragab G.","year":"2017","unstructured":"Ragab G.; Elshahaly M.; Bardin T.; Gout: An old disease in new perspective - A review. J Adv Res 2017,8(5),495-511","journal-title":"J Adv Res"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1002\/art.30493","volume":"63","author":"Pickens S.R.","year":"2011","unstructured":"Pickens S.R.; Chamberlain N.D.; Volin M.V.; Pope R.M.; Talarico N.E.; Mandelin A.M.; Shahrara S.; Characterization of interleukin-7 and interleukin-7 receptor in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 2011,63(10),2884-2893","journal-title":"Arthritis Rheum"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3899\/jrheum.170806","volume":"45","author":"Elfishawi M.M.","year":"2018","unstructured":"Elfishawi M.M.; Zleik N.; Kvrgic Z.; Michet C.J.; Crowson C.S.; Matteson E.L.; Bongartz T.; The Rising Incidence of Gout and the Increasing Burden of Comorbidities: A Population-based Study over 20 Years. J Rheumatol 2018,45(4),574-579","journal-title":"J Rheumatol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","volume":"11","author":"Kuo C.F.","year":"2015","unstructured":"Kuo C.F.; Grainge M.J.; Zhang W.; Doherty M.; Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 2015,11(11),649-662","journal-title":"Nat Rev Rheumatol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.amjmed.2006.06.040","volume":"120","author":"Choi H.K.","year":"2007","unstructured":"Choi H.K.; Ford E.S.; Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007,120(5),442-447","journal-title":"Am J Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.metabol.2008.01.030","volume":"57","author":"Sui X.","year":"2008","unstructured":"Sui X.; Church T.S.; Meriwether R.A.; Lobelo F.; Blair S.N.; Uric acid and the development of metabolic syndrome in women and men. Metabolism 2008,57(6),845-852","journal-title":"Metabolism"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.annepidem.2006.10.001","volume":"17","author":"Ryu S.","year":"2007","unstructured":"Ryu S.; Song J.; Choi B.Y.; Lee S.J.; Kim W.S.; Chang Y.; Kim D.I.; Suh B.S.; Sung K.C.; Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39. Ann Epidemiol 2007,17(4),245-252","journal-title":"Ann Epidemiol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4078\/jrd.2018.25.1.19","volume":"25","author":"Kim S-K.","year":"2018","unstructured":"Kim S-K.; Interrelationship of Uric Acid, Gout, and Metabolic Syndrome: Focus on Hypertension, Cardiovascular Disease, and Insulin Resistance. J Rheum Dis 2018,25(1),19-27","journal-title":"J Rheum Dis"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/art.22466","volume":"57","author":"Choi H.K.","year":"2007","unstructured":"Choi H.K.; Ford E.S.; Li C.; Curhan G.; Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2007,57(1),109-115","journal-title":"Arthritis Rheum"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","volume":"74","author":"Neogi T.","year":"2015","unstructured":"Neogi T.; Jansen T.L.T.A.; Dalbeth N.; Fransen J.; Schumacher H.R.; Berendsen D.; Brown M.; Choi H.; Edwards N.L.; Janssens H.J.E.M.; Liot\u00e9 F.; Naden R.P.; Nuki G.; Ogdie A.; Perez-Ruiz F.; Saag K.; Singh J.A.; Sundy J.S.; Tausche A-K.; Vaquez-Mellado J.; Yarows S.A.; Taylor W.J.; 2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2015,74(10),1789-1798","journal-title":"Ann Rheum Dis"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3164\/jcbn.12-65","volume":"52","author":"Zhang M.L.","year":"2013","unstructured":"Zhang M.L.; Gao Y.X.; Wang X.; Chang H.; Huang G.W.; Serum uric acid and appropriate cutoff value for prediction of metabolic syndrome among Chinese adults. J Clin Biochem Nutr 2013,52(1),38-42","journal-title":"J Clin Biochem Nutr"},{"key":"ref=12","first-page":"552","volume":"3","author":"Rezaianzadeh A.","year":"2012","unstructured":"Rezaianzadeh A.; Namayandeh S.M.; Sadr S.M.; National Cholesterol Education Program Adult Treatment Panel III Versus International Diabetic Federation Definition of Metabolic Syndrome, Which One is Associated with Diabetes Mellitus and Coronary Artery Disease? Int J Prev Med 2012,3(8),552-558","journal-title":"Int J Prev Med"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.3346\/jkms.2005.20.6.1029","volume":"20","author":"Rho Y.H.","year":"2005","unstructured":"Rho Y.H.; Choi S.J.; Lee Y.H.; Ji J.D.; Choi K.M.; Baik S.H.; Chung S.H.; Kim C.G.; Choe J.Y.; Lee S.W.; Chung W.T.; Song G.G.; The prevalence of metabolic syndrome in patients with gout: a multicenter study. J Korean Med Sci 2005,20(6),1029-1033","journal-title":"J Korean Med Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/oxfordjournals.aje.a113972","volume":"121","author":"Brand F.N.","year":"1985","unstructured":"Brand F.N.; McGee D.L.; Kannel W.B.; Stokes J.; Castelli W.P.; Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol 1985,121(1),11-18","journal-title":"Am J Epidemiol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","volume":"41","author":"Lawrence R.C.","year":"1998","unstructured":"Lawrence R.C.; Helmick C.G.; Arnett F.C.; Deyo R.A.; Felson D.T.; Giannini E.H.; Heyse S.P.; Hirsch R.; Hochberg M.C.; Hunder G.G.; Liang M.H.; Pillemer S.R.; Steen V.D.; Wolfe F.; Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998,41(5),778-799","journal-title":"Arthritis Rheum"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/ar3199","volume":"12","author":"Roddy E.","year":"2010","unstructured":"Roddy E.; Doherty M.; Epidemiology of gout. Arthritis Res Ther 2010,12(6),223","journal-title":"Arthritis Res Ther"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11926-012-0307-x","volume":"15","author":"Singh J.A.","year":"2013","unstructured":"Singh J.A.; Racial and gender disparities among patients with gout. Curr Rheumatol Rep 2013,15(2),307","journal-title":"Curr Rheumatol Rep"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.rdc.2014.07.002","volume":"40","author":"MacFarlane L.A.","year":"2014","unstructured":"MacFarlane L.A.; Kim S.C.; Gout: a review of nonmodifiable and modifiable risk factors. Rheum Dis Clin North Am 2014,40(4),581-604","journal-title":"Rheum Dis Clin North Am"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"821971","DOI":"10.4061\/2011\/821971","volume":"2011","author":"Sharma S.K.","year":"2011","unstructured":"Sharma S.K.; Ghimire A.; Radhakrishnan J.; Thapa L.; Shrestha N.R.; Paudel N.; Gurung K.; R M.; Budathoki A.; Baral N.; Brodie D.; Prevalence of hypertension, obesity, diabetes, and metabolic syndrome in Nepal. Int J Hypertens 2011,2011,821971","journal-title":"Int J Hypertens"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/01.rhu.0000129082.42094.fc","volume":"10","author":"V\u00e1zquez-Mellado J.","year":"2004","unstructured":"V\u00e1zquez-Mellado J.; Garc\u00eda C.G.; V\u00e1zquez S.G.; Medrano G.; Ornelas M.; Alcocer L.; Marquez A.; Burgos-Vargas R.; Metabolic syndrome and ischemic heart disease in gout. J Clin Rheumatol 2004,10(3),105-109","journal-title":"J Clin Rheumatol"},{"key":"ref=21","doi-asserted-by":"crossref","DOI":"10.1186\/s41256-019-0102-6","volume":"4","author":"Huang Y.","year":"2019","unstructured":"Huang Y.; Guo P.; Karmacharya B. M.; Seeruttun S. R.; Xu D. R.; Hao Y.; Prevalence of hypertension and prehypertension in Nepal: a systematic review and meta-analysis. Global health research and policy 2019,4(11)","journal-title":"Global health research and policy"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S2221-1691(14)60209-4","volume":"4","author":"Poudel B.","year":"2014","unstructured":"Poudel B.; Yadav B.K.; Kumar A.; Jha B.; Raut K.B.; Serum uric acid level in newly diagnosed essential hypertension in a Nepalese population: a hospital based cross sectional study. Asian Pac J Trop Biomed 2014,4(1),59-64","journal-title":"Asian Pac J Trop Biomed"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijcard.2010.10.033","volume":"156","author":"Lin C.S.","year":"2012","unstructured":"Lin C.S.; Lee W.L.; Hung Y.J.; Lee D.Y.; Chen K.F.; Chi W.C.; Chang S.C.; Prevalence of hyperuricemia and its association with antihypertensive treatment in hypertensive patients in Taiwan. Int J Cardiol 2012,156(1),41-46","journal-title":"Int J Cardiol"},{"key":"ref=24","first-page":"11","volume":"66","author":"Tiwaskar M.","year":"2018","unstructured":"Tiwaskar M.; Hypertension and Hyperuricemia: A Compelling Correlation. J Assoc Physicians India 2018,66(1),11-12","journal-title":"J Assoc Physicians India"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40885-015-0022-9","volume":"21","author":"Lee J.J.","year":"2015","unstructured":"Lee J.J.; Ahn J.; Hwang J.; Han S.W.; Lee K.N.; Kim J.B.; Lee S.; Na J.O.; Lim H.E.; Kim J.W.; Rha S.W.; Park C.G.; Seo H.S.; Oh D.J.; Kim E.J.; Relationship between uric acid and blood pressure in different age groups. Clin Hypertens 2015,21,14","journal-title":"Clin Hypertens"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"9061","DOI":"10.1038\/s41598-019-45680-4","volume":"9","author":"Ali N.","year":"2019","unstructured":"Ali N.; Mahmood S.; Islam F.; Relationship between serum uric acid and hypertension: a cross-sectional study in Bangladeshi adults 2019,9(1),9061"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1093\/rheumatology\/keq274","volume":"49","author":"Dao H.H.","year":"2010","unstructured":"Dao H.H.; Harun-Or-Rashid M.; Sakamoto J.; Body composition and metabolic syndrome in patients with primary gout in Vietnam. Rheumatology (Oxford) 2010,49(12),2400-2407","journal-title":"Rheumatology (Oxford)"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.diabres.2003.12.007","volume":"65","author":"Lee W.Y.","year":"2004","unstructured":"Lee W.Y.; Park J.S.; Noh S.Y.; Rhee E.J.; Kim S.W.; Zimmet P.Z.; Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res Clin Pract 2004,65(2),143-149","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=29","first-page":"975","volume":"20","author":"Bonora E.","year":"1996","unstructured":"Bonora E.; Targher G.; Zenere M.B.; Saggiani F.; Cacciatori V.; Tosi F.; Travia D.; Zenti M.G.; Branzi P.; Santi L.; Muggeo M.; Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 1996,20(11),975-980","journal-title":"Int J Obes Relat Metab Disord"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"e105056","DOI":"10.1371\/journal.pone.0105056","volume":"9","author":"Moreira G.C.","year":"2014","unstructured":"Moreira G.C.; Cipullo J.P.; Ciorlia L.A.; Cesarino C.B.; Vilela-Martin J.F.; Prevalence of metabolic syndrome: association with risk factors and cardiovascular complications in an urban population. PLoS One 2014,9(9),e105056","journal-title":"PLoS One"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530320999200818141032","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184989\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530320999200818141032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T06:05:05Z","timestamp":1657173905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184989\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530320999200818141032","relation":{},"ISSN":["1871-5303"],"issn-type":[{"type":"print","value":"1871-5303"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-03-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}